Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania.

@article{Bonafede2015ImpactOO,
  title={Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania.},
  author={Machaon M K Bonafede and Julie C. Locklear and Peter Wahlqvist and Liberty Fajutrao and Johan Szamosi and Katy Pan and Hans Eriksson},
  journal={Journal of comparative effectiveness research},
  year={2015},
  volume={4 1},
  pages={51-9}
}
AIMS Evaluate the impact of quetiapine extended release (XR) versus quetiapine immediate release (IR) on hospitalization length in acute bipolar mania using Truven Health Analytics MarketScan Hospital Drug Database. PATIENTS & METHODS Generalized linear model analyses were used, adjusting for patient and hospital characteristics. RESULTS Using data from 3088 discharges, quetiapine XR reduced hospitalization length by 6.7% versus quetiapine IR (p = 0.11; no statistically significant… CONTINUE READING